>>Signaling Pathways>> Membrane Transporter/Ion Channel>> P-glycoprotein>>(R)-Verapamil D7 hydrochloride

(R)-Verapamil D7 hydrochloride (Synonyms: (R)-(+)-Verapamil D7 hydrochloride)

Catalog No.GC60407

(R)-Verapamil D7 염산염((R)-(+)-Verapamil D7 염산염)은 (R)-Verapamil 염산염으로 표지된 중수소입니다. (R)-베라파밀 염산염((R)-(+)-베라파밀 염산염)은 P-당단백질 억제제입니다. (R)-Verapamil 염산염은 MRP1 매개 수송을 차단하여 MRP1을 과발현하는 세포가 항암제에 화학 민감화되도록 합니다.

Products are for research use only. Not for human use. We do not sell to patients.

(R)-Verapamil D7 hydrochloride Chemical Structure

Size 가격 재고 수량
1mg
US$213.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com


고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(R)-Verapamil D7 hydrochloride ((R)-(+)-Verapamil D7 hydrochloride) is a deuterium labeled (R)-Verapamil hydrochloride. (R)-Verapamil hydrochloride ((R)-(+)-Verapamil hydrochloride) is a P-Glycoprotein inhibitor. (R)-Verapamil hydrochloride blocks MRP1 mediated transport, resulting in chemosensitization of MRP1-overexpressing cells to anticancer drugs[1][2].

[1]. Plumb JA, et al. The activity of verapamil as a resistance modifier in vitro in drug resistant human tumour cell lines is not stereospecific. Biochem Pharmacol. 1990 Feb 15;39(4):787-92. [2]. Perrotton T, et al. (R)- and (S)-verapamil differentially modulate the multidrug-resistant protein MRP1. J Biol Chem. 2007 Oct 26;282(43):31542-8. Epub 2007 Jul 22.

리뷰

Review for (R)-Verapamil D7 hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 16 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (R)-Verapamil D7 hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.